genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2023

Epidermal growth factor

Engineered Nanoparticles Target Various Biological Targets
News

Engineered Nanoparticles Target Various Biological Targets

Christina Jackson -
October 30, 2023
0
Triple-Negative Breast Cancer’s Molecular Changes Revealed
Cancer

Triple-Negative Breast Cancer’s Molecular Changes Revealed

Julianna LeMieux, PhD -
August 10, 2022
0
Anti-Pertuzumab Antibodies
New Products

Anti-Pertuzumab Antibodies

Christina Jackson -
March 3, 2022
0
New Therapy Targets Aggressive Chemotherapy-Resistant Breast Cancer
Cancer

New Therapy Targets Aggressive Chemotherapy-Resistant Breast Cancer

Anjali A. Sarkar, PhD -
August 4, 2021
0
Clovis, CEO, Ex-CFO Agree to Pay $20M+ to Settle SEC Charges
News

Clovis, CEO, Ex-CFO Agree to Pay $20M+ to Settle SEC Charges

GEN Staff Writer -
September 19, 2018
0
Opioid Painkillers Could Be Replaced by Cancer Drugs
Drug Discovery

Opioid Painkillers Could Be Replaced by Cancer Drugs

GEN Staff Writer -
August 9, 2017
0
AstraZeneca’s Imfinzi Drug Combo Fails in Phase III Lung Cancer Trial
Drug Discovery

AstraZeneca’s Imfinzi Drug Combo Fails in Phase III Lung Cancer Trial

GEN Staff Writer -
July 27, 2017
0
Targeting CD44s Molecule May Open New Door to Improved Cancer Therapies
Cancer

Targeting CD44s Molecule May Open New Door to Improved Cancer Therapies

GEN Staff Writer -
July 19, 2017
0
China Approves AstraZeneca’s Tagrisso for NSCLC with EGFR Mutation
Drug Discovery

China Approves AstraZeneca’s Tagrisso for NSCLC with EGFR Mutation

GEN Staff Writer -
March 27, 2017
0
Threshold Pharmaceuticals, Molecular Templates to Merge
Cancer

Threshold Pharmaceuticals, Molecular Templates to Merge

GEN Staff Writer -
March 17, 2017
0
1234Page 1 of 4

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up